Breakthrough infections due to the Omicron variant of COVID-19 infection in Myanmar in June 2022: The value of surveillance and early quarantine to prevent fifth wave
Main Article Content
Abstract
The “severe acute respiratory syndrome coronavirus type 2” (SARS-CoV-2) is also known as “coronavirus disease 19” (COVID-19). It originated in Wuhan, Hubei province, People’s Republic of China, in December 2019; and, it spread worldwide causing a global pandemic. Genetic variants of SARS-CoV-2 have been emerging and circulating around the world throughout the COVID-19 pandemic. The original (wild-type) SARS-CoV-2 coronavirus that causes COVID-19 has been changing; and, it has reproduced several new variants- the original (wild-type), the Alpha variant, the Beta variant, the Delta variant, the Gamma variant and the Omicron. the Omicron variant was first detected in South Africa in late November; and, it was found in Myanmar in January 2022 (Pyar, 2022).
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Andrews, N., Stowe, J., Kirsebom, F., Toffa, S., Rickeard, T., Gallagher, E., Gower, C., Kall, M., Groves, N., O’Connell, A.-M., Simons, D., Blomquist, P. B., Zaidi, A., Nash, S., Iwani Binti Abdul Aziz, N., Thelwall, S., Dabrera, G., Myers, R., Amirthalingam, G., … Lopez Bernal, J. (2022). Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. New England Journal of Medicine, 386(16), 1532–1546. https://doi.org/10.1056/NEJMoa2119451
II. Björk, J., Bonander, C., Moghaddassi, M., Rasmussen, M., Malmqvist, U., Inghammar, M., & Kahn, F. (2022). COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants – surveillance results from southern Sweden, December 2021 to March 2022. In Eurosurveillance (Vol. 27, Issue 18, p. 2200322).
III. Brandal, L. T., MacDonald, E., Veneti, L., Ravlo, T., Lange, H., Naseer, U., Feruglio, S., Bragstad, K., Hungnes, O., Ødeskaug, L. E., Hagen, F., Hanch-Hansen, K. E., Lind, A., Watle, S. V., Taxt, A. M., Johansen, M., Vold, L., Aavitsland, P., Nygård, K., & Madslien, E. H. (2021). Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021. In Eurosurveillance (Vol. 26, Issue 50, p. 2101147).
IV. Larkin, H. D. (2022). Four Vaccine Doses Prevented Severe Omicron COVID-19 Better Than 3. JAMA, 327(18), 1748–1748. https://doi.org/10.1001/jama.2022.7248
V. Nations Online. (2022, June 23). Administrative Map of Myanmar.
https://www.nationsonline.org/oneworld/map/Myanmar-administrative-map.htm
VI. Public Health Ontario. (2021). COVID-19 Variant of Concern Omicron (B.1.1.529). https://www.publichealthontario.ca/-/media/documents/ncov/voc/2022/01/covid-19-omicron-b11529-risk-assessment-jan-12.pdf?sc_lang=en
VII. Pyar, K. P. (2022). Breakthrough infections due to SARS-CoV-2 Wild type, the Delta variant and the Omicron variant in early fourth wave of epidemics in Myanmar. International Journal Of Medical Science And Clinical Research Studies, 02(02). https://doi.org/10.47191/ijmscrs/v2-i2-10
VIII. UK Health Security Agency,. (2021). SARS-CoV-2 variants of concern and variants under investigation in England. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1045619/Technical-Briefing-31-Dec-2021-Omicron_severity_update.pdf
IX. WHO. (2022). WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/
X. World Health Organization,. (2021). Update on Omicron. https://www.who.int/news/item/28-11-2021-update-on-omicron
XI. World Health Organization,. (2022). COVID-19
XII. Worldometer. (2022). Learn more about Worldometer’s COVID-19 data.